When did HealthEquity report Q2 2026 earnings?

HealthEquity (HQY) reported Q2 2026 earnings on September 2, 2025 after market close.

What were HealthEquity's Q2 2026 revenue and EPS?

HealthEquity reported revenue of $325.8M and diluted EPS of $1.08 for Q2 2026.

Did HealthEquity beat estimates in Q2 2026?

Revenue beat the consensus estimate of $320.7M by $5.1M. EPS beat the consensus estimate of $0.91 by $0.17.

How did HealthEquity's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 8.6% from $299.9M a year earlier and diluted EPS grew 25.6% from $0.86.

Where can I find HealthEquity's Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001428336-25-000029) directly on SEC EDGAR. The filing index links above go to sec.gov.

HealthEquity HQY Q2 2026 earnings

Reported September 2, 2025 · After market close

Revenue$325.8MBeat by $5.1M Diluted EPS$1.08Beat by $0.17

Revenue estimate$320.7M

EPS estimate$0.91

Next report

Sep 1, 2026 (in 2 months)

Revenue estimate$348.9M

EPS estimate$1.19

Financials

Q2 2026

Income statement

See full

Revenue$325.8M+8.6%

Gross profit$232.6M+14.0%

Operating income$89.6M+52.1%

Net income$59.9M+67.1%

EPS (diluted)$0.68+70.0%

Balance sheet

See full

Cash & equivalents$304.5M-6.9%

Total debt$1.1B-8.8%

Total equity$2.1B-0.5%

Total assets$3.4B-2.8%

Cash flow

See full

Operating cash flow$135.9M+25.7%

CapEx$773.0K+4.3%

Free cash flow$135.1M+25.8%

Valuation & ratios

Q2 2026

Valuation

See full

Market cap$8.39B+23.6%

Enterprise value$9.14B+20.0%

P/E57.5×-6.7×

P/S6.6×+0.4×

Profitability

See full

Gross margin66.4%+1.5pp

Operating margin18.5%+3.0pp

Net margin11.5%+1.9pp

FCF margin28.8%+1.0pp

Returns & leverage

See full

Return on equity6.8%+1.6pp

Debt / equity0.5×0.0×

Current ratio4.2×+0.1×

Segments

By product

See full

Custodial revenue$159.9M+15.3%

Service revenue$117.9M+1.0%

Interchange revenue$48.1M+8.0%

Versus estimates

Revenue

Q1 2027$354.6MBeat by $2.6M Q4 2026$334.6MBeat by $2.3M Q3 2026$322.2MBeat by $1.5M

Q2 2026$325.8MBeat by $5.1M

Q1 2026$330.8MBeat by $8.6M Q4 2025$311.8MBeat by $6.0M

Diluted EPS

Q1 2027$1.24Beat by $0.13 Q4 2026$0.95Beat by $0.06 Q3 2026$1.01Beat by $0.10

Q2 2026$1.08Beat by $0.17

Q1 2026$0.97Beat by $0.16 Q4 2025$0.69Miss by $0.02

Ask the moment HealthEquity reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did HealthEquity report Q2 2026 earnings?: HealthEquity (HQY) reported Q2 2026 earnings on September 2, 2025 after market close.
What were HealthEquity's Q2 2026 revenue and EPS?: HealthEquity reported revenue of $325.8M and diluted EPS of $1.08 for Q2 2026.
Did HealthEquity beat estimates in Q2 2026?: Revenue beat the consensus estimate of $320.7M by $5.1M. EPS beat the consensus estimate of $0.91 by $0.17.
How did HealthEquity's Q2 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 8.6% from $299.9M a year earlier and diluted EPS grew 25.6% from $0.86.
Where can I find HealthEquity's Q2 2026 SEC filings?: You can read the 10-Q periodic report (0001428336-25-000029) directly on SEC EDGAR. The filing index links above go to sec.gov.